[#item_full_content]PARIS–(BUSINESS WIRE)–Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, today announced that it has raised €6.2 million in a seed funding round. The investment was led by Kurma Partners and Heal Capital. This funding will enable Spotlight Medical to bring its first prognosis test to the clinic, marking a significant milestone in the commercialization of AI-based solutions for cancer